Hikal Reports Sequential Performance Recovery in Q4 FY26; Recommends Final Dividend of 20%
Mumbai, May 28: Hikal Limited, a leading global life sciences company, today announced its audited financial results for the quarter and financial year ended March 31, 2026. Consolidated Q4 FY26 Financial Highlights Revenue from Operations stood at ₹519.4 crore, representing a sequential growth of 5% over the preceding quarter (₹494.3 crore). Profit After Tax (PAT)…